PIM Kinases and Their Relevance to the PI3K/AKT/mTOR Pathway in the Regulation of Ovarian Cancer

Biomolecules

Hanqin Wang¹  Kairong Qin²  Aziz Ur Rehman Aziz²  Bo Liu²  Sumbal Farid³ 

[1] Center for Translational Medicine, Suizhou Hospital, Hubei University of Medicine, Suizhou 441300, China;Department of Biomedical Engineering, Dalian University of Technology, Dalian 116024, China;State Key Laboratory of Fine Chemicals, Dalian University of Technology, Dalian 116024, China;

关键词: PI3K/AKT/mTOR pathway;    BAD;    cMyc;    CDK1;   

DOI  :  10.3390/biom8010007

来源: DOAJ

【 摘 要 】

Ovarian cancer is a medical term that includes a number of tumors with different molecular biology, phenotypes, tumor progression, etiology, and even different diagnosis. Some specific treatments are required to address this heterogeneity of ovarian cancer, thus molecular characterization may provide an important tool for this purpose. On a molecular level, proviral-integration site for Moloney-murine leukemia virus (PIM) kinases are over expressed in ovarian cancer and play a vital role in the regulation of different proteins responsible for this tumorigenesis. Likewise, the phosphoinositide 3-kinase (PI3K)/protein kinase B (AKT)/mammalian target of rapamycin (mTOR) pathway is also a central regulator of the ovarian cancer. Interestingly, recent research has linked the PIM kinases to the PI3K/AKT/mTOR pathway in several types of cancers, but their connection in ovarian cancer has not been studied yet. Once the exact relationship of PIM kinases with the PI3K/AKT/mTOR pathway is acquired in ovarian cancer, it will hopefully provide effective treatments on a molecular level. This review mainly focuses on the role of PIM kinases in ovarian cancer and their interactions with proteins involved in its progression. In addition, this review suggests a connection between the PIM kinases and the PI3K/AKT/mTOR pathway and their parallel mechanism in the regulation of ovarian cancer.

【 授权许可】

Unknown